Table 2. Laboratory test results after 5-day treatment.
| Variables | FNC group (n=6) | Non-FNC group (n=7) | P value |
|---|---|---|---|
| WBC (×109/L) | 5.89±3.79 (3.60–5.76) | 8.54±4.53 (5.49–9.85) | 0.76 |
| NEUT (×109/L) | 4.26±4.03 (1.66–4.29) | 7.06±4.58 (3.54–8.73) | 0.49 |
| LYMPH (×109/L) | 1.13±0.39 (0.84–1.28) | 0.67±0.37 (0.49–0.83) | 0.22 |
| hs-CRP (mg/L) | 29.91±34.83 (5.49–36.07) | 80.38±64.62 (15.73–135.85) | <0.05 |
| IL-6 (pg/mL) | 215.36±212.36 (78.34–213.76) | 141.96±125.14 (67.62–149.33) | 0.52 |
| ALT (U/L) | 18.33±18.93 (6.5–18.25) | 36.86±47.08 (9.5–34.5) | <0.05 |
| AST (U/L) | 36.83±30.89 (18.75–34.5) | 124.43±191.06 (21.5–93) | <0.05 |
| LDH (U/L) | 257.67±68.57 (213.75–262.25) | 418.83±363.27 (218.5–336.75) | <0.05 |
| CPK (U/L) | 111.67±67.02 (66–144.25) | 367.83±535.89 (92.5–204.5) | <0.05 |
| CTNI (ng/mL) | 0.03±0.02 (0.03–0.04) | 0.03±0.03 (0.01–0.03) | 0.71 |
| PCT (ng/mL) | 0.59±0.49 (0.18–0.93) | 7.15±13.34 (0.14–5.08) | 0.12 |
| D-dimer (mg/mL) | 20.54±41.86 (1.26–3.49) | 3.32±4.15 (0.88–3.05) | <0.05 |
The data are presented as mean ± standard deviation (range). FNC, azvudine; WBC, white blood cell; NEUT, neutrophils; LYMPH, lymphocytes; hs-CRP, high-sensitivity c-reactive protein; IL-6, interleukin-6; ALT, alanine aminotransferase; AST, aspartate aminotransferase; LDH, lactate dehydrogenase; CPK, creatine phosphokinase; CTNI, cardiac troponin I; PCT, procalcitonin.